CJC-1295 and ipamorelin are investigational peptides that interact with signaling pathways involved in growth hormone release. This compounded combination may be considered by a licensed provider as part of an individualized peptide-therapy plan. Clinical evidence for commonly promoted wellness, recovery, body-composition, and healthy-aging uses remains limited, and individual responses vary.
Choose between a 4-week supply or a 12-week supply. Your selection represents the supply length you are requesting; the prescription, formulation, dosage, injection schedule, and treatment duration remain subject to provider approval and pharmacy requirements.
Your purchase includes a telehealth evaluation for consideration of compounded CJC-1295/ipamorelin. A licensed provider will review your medical history, current medications, treatment goals, and questionnaire responses to determine whether treatment may be appropriate. Additional information, laboratory testing, or ongoing monitoring may be required.
This is a prescription-only service. Purchasing an evaluation does not guarantee approval, a prescription, or specific results. If approved, use the medication only according to the dosing, administration, and storage instructions supplied by your provider and dispensing pharmacy.
Contact your provider if you experience an unexpected reaction. Seek prompt medical attention for severe symptoms such as a rapid heartbeat, fainting, difficulty breathing, significant swelling, or signs of an allergic reaction.
Price range: $232.99 through $544.99
